- Home
- BRR vs TOI Comparison
BRR vs TOI Comparison
Compare BRR & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRR
- TOI
- Stock Information
- Founded
- BRR 2024
- TOI 2007
- Country
- BRR United States
- TOI United States
- Employees
- BRR N/A
- TOI N/A
- Industry
- BRR Blank Checks
- TOI Medical/Nursing Services
- Sector
- BRR Finance
- TOI Health Care
- Exchange
- BRR Nasdaq
- TOI Nasdaq
- Market Cap
- BRR 342.8M
- TOI 393.4M
- IPO Year
- BRR N/A
- TOI N/A
- Fundamental
- Price
- BRR $10.14
- TOI $3.30
- Analyst Decision
- BRR
- TOI Strong Buy
- Analyst Count
- BRR 0
- TOI 1
- Target Price
- BRR N/A
- TOI $6.00
- AVG Volume (30 Days)
- BRR 295.7K
- TOI 1.8M
- Earning Date
- BRR 01-01-0001
- TOI 08-13-2025
- Dividend Yield
- BRR N/A
- TOI N/A
- EPS Growth
- BRR N/A
- TOI N/A
- EPS
- BRR N/A
- TOI N/A
- Revenue
- BRR N/A
- TOI $424,376,000.00
- Revenue This Year
- BRR N/A
- TOI $21.96
- Revenue Next Year
- BRR N/A
- TOI $20.34
- P/E Ratio
- BRR N/A
- TOI N/A
- Revenue Growth
- BRR N/A
- TOI 17.53
- 52 Week Low
- BRR $10.05
- TOI $0.13
- 52 Week High
- BRR $10.42
- TOI $4.50
- Technical
- Relative Strength Index (RSI)
- BRR N/A
- TOI 41.44
- Support Level
- BRR N/A
- TOI $3.33
- Resistance Level
- BRR N/A
- TOI $3.52
- Average True Range (ATR)
- BRR 0.00
- TOI 0.23
- MACD
- BRR 0.00
- TOI -0.08
- Stochastic Oscillator
- BRR 0.00
- TOI 22.71
About BRR Columbus Circle Capital Corp I Class A Ordinary Shares
Columbus Circle Capital Corp I is a blank check company.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.